The store will not work correctly when cookies are disabled.
4-(2-Amino-9H-purin-9-yl)benzamide
ID: ALA4781655
PubChem CID: 121379444
Max Phase: Preclinical
Molecular Formula: C12H10N6O
Molecular Weight: 254.25
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1ccc(-n2cnc3cnc(N)nc32)cc1
Standard InChI: InChI=1S/C12H10N6O/c13-10(19)7-1-3-8(4-2-7)18-6-16-9-5-15-12(14)17-11(9)18/h1-6H,(H2,13,19)(H2,14,15,17)
Standard InChI Key: ABFDUZUCECPOLF-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
18.3576 -14.8978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0673 -14.4884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0645 -13.6657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3559 -13.2605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6496 -14.4889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6508 -13.6678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8703 -13.4129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3866 -14.0765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8683 -14.7414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6177 -15.5135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8168 -15.6811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5630 -16.4571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1092 -17.0662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9124 -16.8940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1624 -16.1182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8565 -17.8433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0572 -18.0131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4033 -18.4507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7757 -14.8959 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 10 1 0
13 16 1 0
16 17 2 0
16 18 1 0
2 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 254.25 | Molecular Weight (Monoisotopic): 254.0916 | AlogP: 0.50 | #Rotatable Bonds: 2 |
Polar Surface Area: 112.71 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.22 | CX LogP: 0.29 | CX LogD: 0.29 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.69 | Np Likeness Score: -1.23 |
References
1. Froux L,Elbahnsi A,Boucherle B,Billet A,Baatallah N,Hoffmann B,Alliot J,Zelli R,Zeinyeh W,Haudecoeur R,Chevalier B,Fortuné A,Mirval S,Simard C,Lehn P,Mornon JP,Hinzpeter A,Becq F,Callebaut I,Décout JL. (2020) Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activity., 190 [PMID:32078860] [10.1016/j.ejmech.2020.112116] |